Proven Sites.
Engaged Physicians.
Predictable Performance.
Tekton Research is the multi-specialty site network built to help Sponsors and CROs activate sites efficiently, reach the right patient populations, and consistently execute at a high level.
Therapeutic Expertise
Leading investigators and real community-driven patient access enable Tekton to recruit hard-to-reach populations without sacrificing speed or scale.
Experience
- Addiction (drug/substance use disorders, alcohol use disorder, smoking and nicotine cessation)
- Allergy and Immunology
- Cardiology/Cardiovascular (hypertension, lipid disorders/dyslipidemia)
- Cognitive and Memory Disorders
- Consumer Health and Over-the-Counter
- Dermatology
- Diagnostics
- Endocrinology and Metabolism (type 1 diabetes, type 2 diabetes, obesity and weight management, dyslipidemia, thyroid disorders)
- Family Medicine
- Gastroenterology
- Hematology
- Infectious Diseases
- Inflammation
- Internal Medicine
- MASH/MASLD
- Medical Devices
- Nephrology
- Neurology (neurodegenerative diseases, Alzheimer’s disease and other dementias, Parkinson’s disease, multiple sclerosis, epilepsy, migraine and headache disorders, cognitive impairment and memory loss)
- Oncology
- Pain (acute, chronic, neuropathic)
- Psychiatry and Behavioral Health (depression, anxiety disorders, bipolar disorder, schizophrenia, ADHD, sleep disorders)
- Pulmonology and Respiratory Disease (asthma, COPD, respiratory infections)
- Rheumatology
- Vaccines
Specialty Populations
- People with multiple chronic conditions or comorbidities
- Pediatrics
- Adolescents
- Geriatrics
- Pregnant and postpartum
- Immunocompromised
- Neurodegenerative
- Neurodivergent
- Racially and ethnically diverse populations
- Rare disease
- Healthy volunteers
- Caregivers and care partners
Case Studies
-
Averaging 170% Enrollment Across Three Type 1 Diabetes Sites
Read Case Study »Across three Texas sites, Tekton delivered consistent enrollment and regulatory performance for a Type 1 diabetes trial. All three sites exceeded their targets. Physician-led database review and detailed prescreening helped the McKinney site move quickly while focusing outreach on participants likely to meet the study requirements.
-
One-Day First Participant Visits and Low Screen Fail Rates for a Pneumococcal Study
Read Case Study »Tekton delivered a Phase 3 pneumococcal vaccine study at sites in Edmond, Oklahoma, and Austin, Texas, with rapid regulatory and activation timelines. The Edmond site was approved to overenroll and then quickly exceeded its goal.
-
Randomizing the First Participant and Reaching 110% of Goal for an Alzheimer’s Study
Read Case Study »Tekton supported a one-site Alzheimer’s disease trial led by a recently trained and onboarded new-to-Tekton Principal Investigator. Tekton also consulted on study design and implementation. The site randomized the study’s first participant, reached 110% of its enrollment goal, and became one of the study’s top enrollers.
-
Randomizing 1,500+ Participants for a Phase 3 Flu Vaccine Program
Read Case Study »Across seven sites in three states, Tekton centralized startup and recruitment for a Phase 3 influenza vaccine research program. All seven sites exceeded their goals, more than 340 participants were randomized at Tekton’s Austin site, and Tekton randomized more than 1,500 participants across the overall research program.
-
300% of Combined Enrollment Goal Achieved in a Phase 2 Obesity Trial
Read Case Study »Tekton’s San Antonio, TX, and Edmond, OK, teams randomized 60 participants in a Phase 2 obesity trial against a combined initial target of 20. Both sites exceeded their individual enrollment goals.
-
Rescue Site Achieves 125% of Enrollment Goal in an Alzheimer’s Trial
Read Case Study »Tekton’s St. Louis team joined an Alzheimer’s trial as a rescue site and achieved 125% of its enrollment goal. The study team included Ernest Graypel, MD, MHA, Brandon Lenfest, and Mejra Dzinic.
-
Reaching 108% of Goal Across Seven Phase 3 Norovirus Vaccine Sites
Read Case Study »Seven Tekton sites across four states supported a global Phase 3 norovirus vaccine trial involving generally healthy adults. A centralized model aligned startup, regulatory, contracting, budgeting, and recruitment activity across the sites, supporting rapid first participant visits and above-goal enrollment.
-
Meeting Enrollment Early With 100% Retention in a Phase 2 Migraine Study
Read Case Study »At Tekton’s Yukon, Oklahoma site (now Oklahoma City), the team delivered a Phase 2 migraine treatment study with rapid startup, early enrollment completion, full participant retention, and near-perfect diary compliance. Participant education and proactive follow-up supported adherence throughout the study.
-
Reaching 120% of Enrollment Goal Across Five Adolescent CMV Vaccine Sites
Read Case Study »Five Tekton sites supported an adolescent cytomegalovirus vaccine study. Recruitment combined targeted digital campaigns, peer referrals, database outreach, and community events, with outreach directed to adolescents and their parents.
-
156% of Enrollment Goal Delivered for a Diabetes Device Study
Read Case Study »Tekton’s McKinney, TX, team achieved 156% of its enrollment goal for a Type 1 and Type 2 diabetes device study led by Pablo Mora, MD, FACE, MSc, CDCES.
-
Delivering 240% of Enrollment Goal With 100% Retention in a CGM Study
Read Case Study »Tekton’s Wichita, Kansas site supported a continuous glucose monitoring device trial involving participants with gestational, type 1, and type 2 diabetes. Personalized outreach to a pre-identified patient pool helped the site exceed enrollment expectations while retaining every participant.
-
Enrolling 720+ Participants Across Seven Phase 3 Flu Vaccine Sites
Read Case Study »Tekton supported a global Phase 3 influenza vaccine trial across seven sites in three states, centralizing startup, regulatory, and recruitment support. Enrollment was open for two months and focused on generally healthy adults aged 50 and older, stratified into three age groups. Centralized startup and year-round recruitment preparation helped the sites move quickly during a…
-
Exceeding the Enrollment Goal for a Phase 3 Social Anxiety Disorder Study
Read Case Study »Tekton supported a Phase 3 social anxiety disorder study at two sites through centralized contracting, startup, and recruitment. Tekton Psychiatry Team leaders served as Principal Investigators, and the study’s total enrollment goal was exceeded.
-
Meeting Enrollment Two Months Early and Reaching 160% of Goal
Read Case Study »At its Austin site, Tekton met the initial enrollment goal for a Phase 2 psoriatic arthritis study two months early. After the sponsor approved overenrollment, the site continued enrolling and ultimately reached 160% of its initial goal.
-
Rapid Startup and Early Enrollment Completion for a GLP-1 Study
Read Case Study »Tekton delivered a Phase 3 GLP-1 medication research study at its Moore, Oklahoma, site. The site moved quickly from startup to enrollment while maintaining a focused, coordinated approach throughout the study.